Treatment of patients with severe sepsis and septic shock: real-life lessons
Pharmaceutical companies have provided a great deal of education focused on products such as rhAPC. Unfortunately, educational funding to promote the use of equally efficacious but inexpensive therapies, such as steroids, fluids or pressure monitoring, is lacking. Early goal-directed therapy saves l...
Gespeichert in:
| Veröffentlicht in: | Canadian journal of emergency medicine 2006-07, Vol.8 (4), p.244-245 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 245 |
|---|---|
| container_issue | 4 |
| container_start_page | 244 |
| container_title | Canadian journal of emergency medicine |
| container_volume | 8 |
| creator | Davidow, Jonathan S. Brindley, Peter G. Jacka, Michael J. Gibney, R.T. Noel |
| description | Pharmaceutical companies have provided a great deal of education focused on products such as rhAPC. Unfortunately, educational funding to promote the use of equally efficacious but inexpensive therapies, such as steroids, fluids or pressure monitoring, is lacking. Early goal-directed therapy saves lives, and mortality increases for each hour that appropriate antibiotics and fluid resuscitation are delayed.2,3 With any time-dependant therapy, it is necessary to expedite a continuum of care. |
| doi_str_mv | 10.1017/S1481803500013750 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_68320742</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S1481803500013750</cupid><galeid>A163047765</galeid><sourcerecordid>A163047765</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4180-586f0bfba761e5adb1c8a45530e03e67036d4e626de4686f6e083bca0a1230143</originalsourceid><addsrcrecordid>eNp1kk9v1DAQxS0EoqXwAbigiAMSh5Rx_BduVVWg0goOLWfLcSZblyRObQfot8erXdEuFM1hRqPfe3oaDSEvKRxToOrdBeWaamACAChTAh6Rw82q1sDZ4z8zEwfkWUrXBWoE1U_JAVWs4QzoIVldRrR5xClXoa9mm30ZU_XT56sq4Q-MWNqcfKrs1G3G7F2VroL7_qEqyqEefI_VgCmFKT0nT3o7JHyx60fk28ezy9PP9errp_PTk1XteIlbCy17aPvWKklR2K6lTlsuBAMEhlIBkx1H2cgOuSysRNCsdRYsbUpozo7Im63vHMPNgimb0SeHw2AnDEsyUrMGFG8K-Pov8DoscSrZDH0vlJaSbdzqLbS2Axo_9SFH69Y4YbRDmLD3ZX1CJQOulBR3pnu8m_2NuQ8dPwCV6nD07kHXt3uCwmT8ldd2ScmcX3zZZ-mWdTGkFLE3c_SjjbeGgtl8hvnnM4rm1e4USztid6fYvUIB2M7Ujm303RrvHeu_tr8B9C696g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195786634</pqid></control><display><type>article</type><title>Treatment of patients with severe sepsis and septic shock: real-life lessons</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Davidow, Jonathan S. ; Brindley, Peter G. ; Jacka, Michael J. ; Gibney, R.T. Noel</creator><creatorcontrib>Davidow, Jonathan S. ; Brindley, Peter G. ; Jacka, Michael J. ; Gibney, R.T. Noel</creatorcontrib><description>Pharmaceutical companies have provided a great deal of education focused on products such as rhAPC. Unfortunately, educational funding to promote the use of equally efficacious but inexpensive therapies, such as steroids, fluids or pressure monitoring, is lacking. Early goal-directed therapy saves lives, and mortality increases for each hour that appropriate antibiotics and fluid resuscitation are delayed.2,3 With any time-dependant therapy, it is necessary to expedite a continuum of care.</description><identifier>ISSN: 1481-8035</identifier><identifier>EISSN: 1481-8043</identifier><identifier>DOI: 10.1017/S1481803500013750</identifier><identifier>PMID: 17324301</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Adrenal Cortex Hormones - therapeutic use ; Anti-Infective Agents - therapeutic use ; Biocides ; Diabetes therapy ; Fluid Therapy ; Humans ; Infection ; Letters • Courrier ; Oximetry ; Practice Guidelines as Topic ; Protein C - therapeutic use ; Quality Assurance, Health Care ; Recombinant Proteins - therapeutic use ; Sepsis - therapy ; Septic shock ; Shock, Septic - therapy ; Triage</subject><ispartof>Canadian journal of emergency medicine, 2006-07, Vol.8 (4), p.244-245</ispartof><rights>Copyright © Canadian Association of Emergency Physicians 2006</rights><rights>COPYRIGHT 2006 Decker Publishing</rights><rights>Copyright Canadian Medical Association Jul 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4180-586f0bfba761e5adb1c8a45530e03e67036d4e626de4686f6e083bca0a1230143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17324301$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Davidow, Jonathan S.</creatorcontrib><creatorcontrib>Brindley, Peter G.</creatorcontrib><creatorcontrib>Jacka, Michael J.</creatorcontrib><creatorcontrib>Gibney, R.T. Noel</creatorcontrib><title>Treatment of patients with severe sepsis and septic shock: real-life lessons</title><title>Canadian journal of emergency medicine</title><addtitle>Can J Emergen Med</addtitle><description>Pharmaceutical companies have provided a great deal of education focused on products such as rhAPC. Unfortunately, educational funding to promote the use of equally efficacious but inexpensive therapies, such as steroids, fluids or pressure monitoring, is lacking. Early goal-directed therapy saves lives, and mortality increases for each hour that appropriate antibiotics and fluid resuscitation are delayed.2,3 With any time-dependant therapy, it is necessary to expedite a continuum of care.</description><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Biocides</subject><subject>Diabetes therapy</subject><subject>Fluid Therapy</subject><subject>Humans</subject><subject>Infection</subject><subject>Letters • Courrier</subject><subject>Oximetry</subject><subject>Practice Guidelines as Topic</subject><subject>Protein C - therapeutic use</subject><subject>Quality Assurance, Health Care</subject><subject>Recombinant Proteins - therapeutic use</subject><subject>Sepsis - therapy</subject><subject>Septic shock</subject><subject>Shock, Septic - therapy</subject><subject>Triage</subject><issn>1481-8035</issn><issn>1481-8043</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kk9v1DAQxS0EoqXwAbigiAMSh5Rx_BduVVWg0goOLWfLcSZblyRObQfot8erXdEuFM1hRqPfe3oaDSEvKRxToOrdBeWaamACAChTAh6Rw82q1sDZ4z8zEwfkWUrXBWoE1U_JAVWs4QzoIVldRrR5xClXoa9mm30ZU_XT56sq4Q-MWNqcfKrs1G3G7F2VroL7_qEqyqEefI_VgCmFKT0nT3o7JHyx60fk28ezy9PP9errp_PTk1XteIlbCy17aPvWKklR2K6lTlsuBAMEhlIBkx1H2cgOuSysRNCsdRYsbUpozo7Im63vHMPNgimb0SeHw2AnDEsyUrMGFG8K-Pov8DoscSrZDH0vlJaSbdzqLbS2Axo_9SFH69Y4YbRDmLD3ZX1CJQOulBR3pnu8m_2NuQ8dPwCV6nD07kHXt3uCwmT8ldd2ScmcX3zZZ-mWdTGkFLE3c_SjjbeGgtl8hvnnM4rm1e4USztid6fYvUIB2M7Ujm303RrvHeu_tr8B9C696g</recordid><startdate>200607</startdate><enddate>200607</enddate><creator>Davidow, Jonathan S.</creator><creator>Brindley, Peter G.</creator><creator>Jacka, Michael J.</creator><creator>Gibney, R.T. Noel</creator><general>Cambridge University Press</general><general>Decker Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISN</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>8FV</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M3G</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>200607</creationdate><title>Treatment of patients with severe sepsis and septic shock: real-life lessons</title><author>Davidow, Jonathan S. ; Brindley, Peter G. ; Jacka, Michael J. ; Gibney, R.T. Noel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4180-586f0bfba761e5adb1c8a45530e03e67036d4e626de4686f6e083bca0a1230143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Biocides</topic><topic>Diabetes therapy</topic><topic>Fluid Therapy</topic><topic>Humans</topic><topic>Infection</topic><topic>Letters • Courrier</topic><topic>Oximetry</topic><topic>Practice Guidelines as Topic</topic><topic>Protein C - therapeutic use</topic><topic>Quality Assurance, Health Care</topic><topic>Recombinant Proteins - therapeutic use</topic><topic>Sepsis - therapy</topic><topic>Septic shock</topic><topic>Shock, Septic - therapy</topic><topic>Triage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Davidow, Jonathan S.</creatorcontrib><creatorcontrib>Brindley, Peter G.</creatorcontrib><creatorcontrib>Jacka, Michael J.</creatorcontrib><creatorcontrib>Gibney, R.T. Noel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Canada</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business & Current Affairs Database</collection><collection>Canadian Business & Current Affairs Database (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>CBCA Reference & Current Events</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Canadian journal of emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Davidow, Jonathan S.</au><au>Brindley, Peter G.</au><au>Jacka, Michael J.</au><au>Gibney, R.T. Noel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of patients with severe sepsis and septic shock: real-life lessons</atitle><jtitle>Canadian journal of emergency medicine</jtitle><addtitle>Can J Emergen Med</addtitle><date>2006-07</date><risdate>2006</risdate><volume>8</volume><issue>4</issue><spage>244</spage><epage>245</epage><pages>244-245</pages><issn>1481-8035</issn><eissn>1481-8043</eissn><abstract>Pharmaceutical companies have provided a great deal of education focused on products such as rhAPC. Unfortunately, educational funding to promote the use of equally efficacious but inexpensive therapies, such as steroids, fluids or pressure monitoring, is lacking. Early goal-directed therapy saves lives, and mortality increases for each hour that appropriate antibiotics and fluid resuscitation are delayed.2,3 With any time-dependant therapy, it is necessary to expedite a continuum of care.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><pmid>17324301</pmid><doi>10.1017/S1481803500013750</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1481-8035 |
| ispartof | Canadian journal of emergency medicine, 2006-07, Vol.8 (4), p.244-245 |
| issn | 1481-8035 1481-8043 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68320742 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Adrenal Cortex Hormones - therapeutic use Anti-Infective Agents - therapeutic use Biocides Diabetes therapy Fluid Therapy Humans Infection Letters • Courrier Oximetry Practice Guidelines as Topic Protein C - therapeutic use Quality Assurance, Health Care Recombinant Proteins - therapeutic use Sepsis - therapy Septic shock Shock, Septic - therapy Triage |
| title | Treatment of patients with severe sepsis and septic shock: real-life lessons |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T10%3A53%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20patients%20with%20severe%20sepsis%20and%20septic%20shock:%20real-life%20lessons&rft.jtitle=Canadian%20journal%20of%20emergency%20medicine&rft.au=Davidow,%20Jonathan%20S.&rft.date=2006-07&rft.volume=8&rft.issue=4&rft.spage=244&rft.epage=245&rft.pages=244-245&rft.issn=1481-8035&rft.eissn=1481-8043&rft_id=info:doi/10.1017/S1481803500013750&rft_dat=%3Cgale_proqu%3EA163047765%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=195786634&rft_id=info:pmid/17324301&rft_galeid=A163047765&rft_cupid=10_1017_S1481803500013750&rfr_iscdi=true |